Scientific revelations are published almost daily in regard to the healing properties of the cannabis, but they aren’t always getting the attention that they so desperately deserve. Here are some of the latest cannabis studies that the mainstream media doesn’t want you to know:

Marijuana Use Is Associated With Decreased Mortality In TBI Patients

Traumatic brain injury (TBI) patients with a history of cannabis use possess increased survival rates compared to non-users, according data published this month in the journal American Surgeon. UCLA Medical Center investigators conducted a three-year retrospective review of brain trauma patients. Data from 446 separate cases of similarly injured patients was assessed. Of those patients who tested positive for the presence of marijuana, 97.6 percent survived surgery.

CBG Administration Halts Cancer Progression

The administration of the nonpsychotropic plant cannabinoid cannabigerol (CBG) possesses potent anti-colon cancer activities and inhibits cancerous tumor growth, according to data published in September in the journal Carcinogenesis. Investigators reported that the compound promoted apoptosis (cancer cell death) and reduced cell growth in colorectal cancer cells. CBG dosing also inhibited colorectal tumor growth in animals.

Parkinson’s Patients Respond Favorably to Cannabis Therapy

Patients with Parkison’s disease report significant improvement following cannabinoid therapy. Writing in September in the Journal of Psychopharmacology, investigators at the University of São Paulo in Brazil reported on the efficacy of the plant cannabinoid cannabidiol (CBD) versus placebo in 21 subjects with Parkinson’s. Authors reported that the administration of 300 mg doses of CBD per day was associated with “significantly different mean total scores” in subjects’ well-being and quality of life compared to placebo.

Marijuana Use Mitigates Symptoms of Opiate Withdrawal

Cannabis consumption is associated with reduced symptoms of opiate withdrawal in subjects undergoing methadone maintenance treatment, according to recent findings published in The American Journal on Addictions. Authors reported that subjects’ pot use during treatment was associated with less severe symptoms of withdrawal on the clinical opiate withdrawal scale (COWS), an index designed to serve as an objective measure of opiate withdrawal.

Inhaled Cannabis Facilitates Disease Remission In Patients With Crohn’s Disease

Inhaling cannabis reduces symptoms of Crohn’s disease compared to placebo in patients who have not been responsive to conventional pharmaceutical therapies, according to clinical trial data published recently in the journal Clinical Gastroenterology and Hepatology. Investigators reported, “Our data show that 8-weeks treatment with THC-rich cannabis, but not placebo, was associated with a significant decrease of 100 points in CDAI (Crohn’s Disease and activity index) scores.” Five of the eleven patients in the study group also reported achieving disease remission (defined as a reduction in patient’s CDAI score by more than 150 points). Overall, inhaled cannabis treatment was associated with “no significant side effects.”

Read Full Story On: alternet